Vanguard Group’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.17M Buy
3,187,346
+871,484
+38% +$594K ﹤0.01% 3510
2025
Q1
$2.11M Buy
2,315,862
+259,686
+13% +$237K ﹤0.01% 3478
2024
Q4
$2.24M Buy
2,056,176
+24,755
+1% +$27K ﹤0.01% 3533
2024
Q3
$1.54M Hold
2,031,421
﹤0.01% 3637
2024
Q2
$2.52M Sell
2,031,421
-251,941
-11% -$312K ﹤0.01% 3486
2024
Q1
$4.32M Buy
2,283,362
+150,457
+7% +$284K ﹤0.01% 3351
2023
Q4
$5.63M Buy
2,132,905
+7,999
+0.4% +$21.1K ﹤0.01% 3238
2023
Q3
$4.89M Buy
2,124,906
+76,382
+4% +$176K ﹤0.01% 3260
2023
Q2
$7.48M Buy
2,048,524
+394,928
+24% +$1.44M ﹤0.01% 3113
2023
Q1
$5.9M Buy
1,653,596
+124,666
+8% +$445K ﹤0.01% 3222
2022
Q4
$4.36M Buy
1,528,930
+6,611
+0.4% +$18.8K ﹤0.01% 3370
2022
Q3
$3.4M Hold
1,522,319
﹤0.01% 3521
2022
Q2
$3.79M Sell
1,522,319
-131,418
-8% -$327K ﹤0.01% 3519
2022
Q1
$8.07M Buy
1,653,737
+102,423
+7% +$500K ﹤0.01% 3265
2021
Q4
$17.5M Sell
1,551,314
-22,406
-1% -$253K ﹤0.01% 2917
2021
Q3
$22.9M Buy
1,573,720
+16,002
+1% +$233K ﹤0.01% 2790
2021
Q2
$18.1M Buy
1,557,718
+3,268
+0.2% +$38.1K ﹤0.01% 2901
2021
Q1
$19M Buy
1,554,450
+109,913
+8% +$1.34M ﹤0.01% 2810
2020
Q4
$18.1M Buy
1,444,537
+63,621
+5% +$796K ﹤0.01% 2689
2020
Q3
$20.8M Buy
1,380,916
+43,256
+3% +$651K ﹤0.01% 2440
2020
Q2
$32.8M Buy
1,337,660
+410,373
+44% +$10.1M ﹤0.01% 2202
2020
Q1
$13.2M Buy
927,287
+37,571
+4% +$533K ﹤0.01% 2486
2019
Q4
$14.1M Buy
889,716
+134,564
+18% +$2.14M ﹤0.01% 2691
2019
Q3
$6.37M Buy
755,152
+143,001
+23% +$1.21M ﹤0.01% 3041
2019
Q2
$5.5M Buy
612,151
+154,639
+34% +$1.39M ﹤0.01% 3131
2019
Q1
$3.54M Buy
457,512
+163,240
+55% +$1.26M ﹤0.01% 3267
2018
Q4
$1.38M Sell
294,272
-367,344
-56% -$1.73M ﹤0.01% 3471
2018
Q3
$5.99M Sell
661,616
-6,723
-1% -$60.8K ﹤0.01% 3159
2018
Q2
$7.93M Buy
668,339
+216,476
+48% +$2.57M ﹤0.01% 3016
2018
Q1
$6.35M Buy
+451,863
New +$6.35M ﹤0.01% 3046